The U.S. House of Representatives has approved its version of the National Defense Authorization Act (NDAA), authorizing nearly $900 billion in military spending for 2025. The measure, passed 231–196 largely along party lines, mirrors last year’s funding levels but has drawn sharp debate over partisan amendments.
All but four Republicans supported the bill, while most Democrats opposed it due to provisions touching on divisive social issues. One controversial amendment would bar Pentagon health insurance from covering gender-related medical care. Representative Adam Smith of Washington, the top Democrat on the House Armed Services Committee, criticized Republicans for advancing what he called a “culture war agenda” rather than addressing national security priorities.
Republican chairman of the committee, Representative Mike Rogers of Alabama, celebrated the bill’s passage, calling it a vote to modernize the military, strengthen deterrence, and support service members. The legislation provides a 3.8% pay raise for troops and seeks to overhaul the defense acquisition process by cutting approval delays and expanding investment in artificial intelligence research.
Efforts to cut funding for Ukraine and Taiwan were rejected. However, the bill reignited political battles after Senate Democrats attempted to push an amendment requiring the release of files related to Jeffrey Epstein. Republicans blocked the move, reflecting the case’s lingering political sensitivity given former President Donald Trump’s past ties to Epstein.
The Senate is working on its own NDAA version, which proposes $32 billion more in defense spending. Once passed, both chambers must reconcile differences before sending the final bill to the White House for Trump’s approval or veto.
With military modernization, troop pay raises, and geopolitical support at stake, the NDAA’s fate underscores the deep partisan divides shaping U.S. defense policy.


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
New York Legalizes Medical Aid in Dying for Terminally Ill Patients
Trump Threatens 50% Tariff on Canadian Aircraft Amid Escalating U.S.-Canada Trade Dispute
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Illinois Joins WHO Global Outbreak Network After U.S. Exit, Following California’s Lead
Trump Allows Commercial Fishing in Protected New England Waters
Trump Allegedly Sought Airport, Penn Station Renaming in Exchange for Hudson River Tunnel Funding
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
U.S. Eases Venezuela Oil Sanctions to Boost American Investment After Maduro Ouster
U.S. to Begin Paying UN Dues as Financial Crisis Spurs Push for Reforms
Federal Judge Blocks Trump Administration Move to End TPS for Haitian Immigrants
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Trump to Announce New Federal Reserve Chair Pick as Powell Replacement Looms 



